Mycosis vaccines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61P 31/10 (2006.01) A61P 37/04 (2006.01) C12N 1/14 (2006.01) C12N 1/16 (2006.01) C12N 1/36 (2006.01)

Patent

CA 2268138

The present invention pertains to vaccines comprising homogenised inactivated yeast blastospores and homogenised inactivated dermatophyte microconidia or antigenic material of said pores, methods for their production and their use for the prophylaxis and/or treatment of mycoses in mammals, preferably humans. The vaccines according to the present invention are especially useful for the prophylaxis and/or treatement of skin mycosis, preferably Dermatomycosis and/or Candidosis and/or Onychomycosis.

La présente invention appartient au domaine des vaccins comprenant des blastospores de levure, inactivés et homogénéisés, ainsi que des microconidiospores de dermatophytes inactivés et homogénéisés, ou un matériau antigénique de ces spores, des procédés de production de ces vaccins ainsi que l'utilisation de ceux-ci dans la prophylaxie et/ou le traitement de mycoses chez les mammifères, notamment chez l'homme. Les vaccins de la présente invention sont particulièrement utiles dans la prophylaxie et/ou le traitement de mycoses de la peau, notamment de dermatomycoses et/ou de candidoses et/ou d'onychomycoses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mycosis vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycosis vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycosis vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2026668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.